Gilead Sciences (GILD) reported Q4 non-GAAP earnings late Tuesday of $1.90 per diluted share, up from $1.72 a year earlier.
Analysts polled by FactSet expected $1.74.
Revenue for the quarter ended Dec. 31 was $7.57 billion, up from $7.12 billion a year earlier.
Analysts surveyed by FactSet expected $7.15 billion.
The company said it expects 2025 non-GAAP diluted EPS between $7.70 and $8.10.
Analysts polled by FactSet expect $7.61.
Shares of Gilead Sciences were up 4% in after-hours activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。